MilliporeSigma, the life science business of Germany-based Merck KGaA, reports that it is investing €35 million ($37 million) in biosafety testing at its Glasgow and Stirling sites in Scotland. The ...

MilliporeSigma, Merck KGaA’s life science business, opened the second phase of its new €29 million ($31.7 million) Biologics Testing Center in China, adding 1,500 m 2 to the lab opened last year.

Merck’s life science business has been awarded a three-year, $136.7 million contract to stand up a factory for a critical material needed to manufacture rapid COVID-19 point-of-care tests.

PHILADELPHIA/NEW YORK (Reuters) - Laboratory equipment maker Thermo Fisher Scientific Inc has offered $6 billion to buy Millipore Corp, according to a person familiar with the situation, in a deal ...